- Home
- ATAI vs PSEC Comparison
ATAI vs PSEC Comparison
Compare ATAI & PSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATAI | PSEC |
|---|---|---|
| Founded | 2018 | 2004 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2021 | 2004 |
Fundamental Metrics
Financial Performance| Metric | ATAI | PSEC |
|---|---|---|
| Price | $4.32 | $2.63 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 5 | 1 |
| Target Price | ★ $14.00 | $2.50 |
| AVG Volume (30 Days) | ★ 3.6M | 3.3M |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 20.53% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,018,000.00 | ★ $680,752,000.00 |
| Revenue This Year | $943.83 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 811.78 | N/A |
| 52 Week Low | $1.15 | $2.52 |
| 52 Week High | $6.75 | $4.50 |
Technical Indicators
Market Signals| Indicator | ATAI | PSEC |
|---|---|---|
| Relative Strength Index (RSI) | 49.78 | 42.88 |
| Support Level | $4.25 | $2.61 |
| Resistance Level | $4.54 | $2.71 |
| Average True Range (ATR) | 0.22 | 0.05 |
| MACD | 0.10 | 0.00 |
| Stochastic Oscillator | 71.36 | 22.73 |
Price Performance
Historical ComparisonAbout ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.
About PSEC Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.